BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Emilia Hadziyannis, Stephanos Hadziyannis. Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis BExpert Review of Gastroenterology & Hepatology 2020; 14(4): 243 doi: 10.1080/17474124.2020.1738219
2
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis BClinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
3
Dheyaa Hussein Mohsin, Muthana Saleh Mashkour, Fataneh Fatemi. Design of aptamer-based sensing platform using gold nanoparticles functionalized reduced graphene oxide for ultrasensitive detection of Hepatitis B virusChemical Papers 2020;  doi: 10.1007/s11696-020-01292-1
4
Magda Rybicka, Krzysztof Piotr Bielawski. Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus InfectionMicroorganisms 2020; 8(9): 1416 doi: 10.3390/microorganisms8091416
5
Takako Inoue, Yasuhito Tanaka. The Role of Hepatitis B Core-Related AntigenGenes 2019; 10(5): 357 doi: 10.3390/genes10050357
6
Guanghua Ma, Bin Lou, Feifei Lv, Dejian Zhao, Hui Chen, Xianfei Ye, Yu Chen. HBcrAg, pg RNA and HBsAg dynamically supervise the seroconversion of HBsAg with anti-viral therapyClinica Chimica Acta 2020; 501: 264 doi: 10.1016/j.cca.2019.10.049
7
Ian Baudi, Takako Inoue, Yasuhito Tanaka. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGiInternational Journal of Molecular Sciences 2020; 21(3): 949 doi: 10.3390/ijms21030949